Close

News

Global Biopharma CMO & CRO Market – Almost 6% CAGR Expected

It is well to be noted that the worldwide biopharmaceutical CMO as well as CRO market is anticipated to witness quite significant growth in the next decade. The market, which happens to be valued at $34 billion in 2023,...

New Australia Biomedical Space Driving Innovation, Research

It is worth noting that the new Australian Institute for Infectious Diseases- AIID has been established so as to bring together some of the country’s greatest scientific as well as medical research minds in order to offer a quick...

An Australian Advancement – Titan Krios G4 Microscope Launch

In May 2024, the Ramaciotti Centre for Cryo-Electron Microscopy went on to launch the Titan Krios G4 microscope, a state-of-the-art instrument that happens to be one of the most advanced microscopes from Australia. It is well to be noted that...

The Parenteral Drug Administration – An Evolving Spectrum

Parenteral drug administration has gone on to witness quite a significant set of advancements as well as transformations in recent years. This very crucial method when it comes to drug delivery happens to be playing a very pivotal role when...

Respiratory Syncytial Virus Jab From Moderna Gets FDA Nod

Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older. It is well to be noted that...

Meaningful Investment To Enable Tirzepatide API Production

It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon, Indiana, US has gone on to raise the organization’s total investment in the country from...

Germany – Taking Right Steps Towards Pharma Drugs Reshoring

As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened. The objectives include...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read